JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 22, 2004; DOI: 10.1124/jpet.104.079541


0022-3565/05/3131-16-23$20.00
JPET 313:16-23, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.079541v1
313/1/16    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uberti, M. A.
Right arrow Articles by Hall, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uberti, M. A.
Right arrow Articles by Hall, R. A.

CELLULAR AND MOLECULAR

Heterodimerization with {beta}2-Adrenergic Receptors Promotes Surface Expression and Functional Activity of {alpha}1D-Adrenergic Receptors

Michelle A. Uberti1, Chris Hague, Heide Oller, Kenneth P. Minneman, and Randy A. Hall

Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia

The {alpha}1D-adrenergic receptor ({alpha}1D-AR) is a G protein-coupled receptor (GPCR) that is poorly trafficked to the cell surface and largely nonfunctional when heterologously expressed by itself in a variety of cell types. We screened a library of approximately 30 other group I GPCRs in a quantitative luminometer assay for the ability to promote {alpha}1D-AR cell surface expression. Strikingly, these screens revealed only two receptors capable of inducing robust increases in the amount of {alpha}1D-AR at the cell surface: {alpha}1B-AR and {beta}2-AR. Confocal imaging confirmed that coexpression with {beta}2-AR resulted in translocation of {alpha}1D-AR from intracellular sites to the plasma membrane. Additionally, coimmunoprecipitation studies demonstrated that {alpha}1D-AR and {beta}2-AR specifically interact to form heterodimers when coexpressed in HEK-293 cells. Ligand binding studies revealed an increase in total {alpha}1D-AR binding sites upon coexpression with {beta}2-AR, but no apparent effect on the pharmacological properties of the receptors. In functional studies, coexpression with {beta}2-AR significantly enhanced the coupling of {alpha}1D-AR to norepinephrine-stimulated Ca2+ mobilization. Heterodimerization of {beta}2-AR with {alpha}1D-AR also conferred the ability of {alpha}1D-AR to cointernalize upon {beta}2-AR agonist stimulation, revealing a novel mechanism by which these different adrenergic receptor subtypes may regulate each other's activity. These findings demonstrate that the selective association of {alpha}1D-AR with other receptors is crucial for receptor surface expression and function and also shed light on a novel mechanism of cross talk between {alpha}1- and {beta}2-ARs that is mediated through heterodimerization and cross-internalization.


Received October 20, 2004; accepted December 16, 2004.

Address correspondence to: Randy A. Hall, Department of Pharmacology, Emory University School of Medicine, 5113 Rollins Research Center, 1510 Clifton Rd., Atlanta, GA 30322. E-mail: rhall{at}pharm.emory.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. S. Lyssand, M. C. DeFino, X.-b. Tang, A. L. Hertz, D. B. Feller, J. L. Wacker, M. E. Adams, and C. Hague
Blood Pressure Is Regulated by an {alpha}1D-Adrenergic Receptor/Dystrophin Signalosome
J. Biol. Chem., July 4, 2008; 283(27): 18792 - 18800.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. Rozenfeld and L. A. Devi
Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3
FASEB J, July 1, 2008; 22(7): 2311 - 2322.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Chakera, R. M. Seeber, A. E. John, K. A. Eidne, and D. R. Greaves
The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization
Mol. Pharmacol., May 1, 2008; 73(5): 1362 - 1370.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. M. Conn, A. Ulloa-Aguirre, J. Ito, and J. A. Janovick
G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo
Pharmacol. Rev., September 1, 2007; 59(3): 225 - 250.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Zelazny, J. W. Borst, M. Muylaert, H. Batoko, M. A. Hemminga, and F. Chaumont
FRET imaging in living maize cells reveals that plasma membrane aquaporins interact to regulate their subcellular localization
PNAS, July 24, 2007; 104(30): 12359 - 12364.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. R. Whorton, M. P. Bokoch, S. G. F. Rasmussen, B. Huang, R. N. Zare, B. Kobilka, and R. K. Sunahara
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein
PNAS, May 1, 2007; 104(18): 7682 - 7687.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. T. Drake, S. K. Shenoy, and R. J. Lefkowitz
Trafficking of G Protein-Coupled Receptors
Circ. Res., September 15, 2006; 99(6): 570 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Herrick-Davis, B. A. Weaver, E. Grinde, and J. E. Mazurkiewicz
Serotonin 5-HT2C Receptor Homodimer Biogenesis in the Endoplasmic Reticulum: REAL-TIME VISUALIZATION WITH CONFOCAL FLUORESCENCE RESONANCE ENERGY TRANSFER
J. Biol. Chem., September 15, 2006; 281(37): 27109 - 27116.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. C. Prinster, T. G. Holmqvist, and R. A. Hall
{alpha}2C-Adrenergic Receptors Exhibit Enhanced Surface Expression and Signaling upon Association with beta2-Adrenergic Receptors
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 974 - 981.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. M. van Rijn, P. L. Chazot, F. C. Shenton, K. Sansuk, R. A. Bakker, and R. Leurs
Oligomerization of Recombinant and Endogenously Expressed Human Histamine H4 Receptors
Mol. Pharmacol., August 1, 2006; 70(2): 604 - 615.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Chen, C. Hague, R. A. Hall, and K. P. Minneman
Syntrophins Regulate {alpha}1D-Adrenergic Receptors through a PDZ Domain-mediated Interaction
J. Biol. Chem., May 5, 2006; 281(18): 12414 - 12420.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. M. Filipeanu, F. Zhou, E. K. Fugetta, and G. Wu
Differential Regulation of the Cell-Surface Targeting and Function of beta- and {alpha}1-Adrenergic Receptors by Rab1 GTPase in Cardiac Myocytes
Mol. Pharmacol., May 1, 2006; 69(5): 1571 - 1578.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Bakker, A. F. Lozada, A. van Marle, F. C. Shenton, G. Drutel, K. Karlstedt, M. Hoffmann, M. Lintunen, Y. Yamamoto, R. M. van Rijn, et al.
Discovery of Naturally Occurring Splice Variants of the Rat Histamine H3 Receptor That Act as Dominant-Negative Isoforms
Mol. Pharmacol., April 1, 2006; 69(4): 1194 - 1206.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. Finch and R. M. Graham
The {alpha}1D-Adrenergic Receptor: Cinderella or Ugly Stepsister
Mol. Pharmacol., January 1, 2006; 69(1): 1 - 4.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Hague, S. E. Lee, Z. Chen, S. C. Prinster, R. A. Hall, and K. P. Minneman
Heterodimers of {alpha}1B- and {alpha}1D-Adrenergic Receptors Form a Single Functional Entity
Mol. Pharmacol., January 1, 2006; 69(1): 45 - 55.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. C. Prinster, C. Hague, and R. A. Hall
Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance
Pharmacol. Rev., September 1, 2005; 57(3): 289 - 298.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.